Founded in 1946, Shenzhen People's Hospital was formerly Bao’an County Health Center. It was renamed as Bao’an County People's Hospital after the founding of People’s Republic of China in 1949. Since it was the only hospital with inpatient care in Shenzhen back then, local Cantonese residents called it “Liuyibu” (meaning “inpatient care unit” in Cantonese). Since then, this colloquial term has long been the alternate of the hospital until today. It was again renamed as Shenzhen People’s Hospital after the establishment of the Shenzhen Special Economic Zone in 1979. In 1994, the hospital was recognized as the first Grade 3A hospital in Shenzhen. In 1996, it was approved by the Overseas Chinese Affairs Office to be the Second Hospital Affiliated to Jinan University. In 2005, it was endorsed further as the Second Clinical Medical College of Jinan University. In 2018, with the endorsement from the municipal government, the hospital became the First Hospital Affiliated to Southern University of Science and Technology. Shenzhen People’s Hospital is now the largest modern hospital in the city, with advanced equipment, outstanding staff, state-of-the-art scientific research, top education and medical training, and it provides people with comprehensive medical services.
Shenzhen People’s Hospital covers 152,756 square meters, with a floor area of 0.3 million square meters. The hospital has 2,500 beds and more than 5,000 employees, including 1,000 senior attending doctors and 1,200 intermediate-level attending doctors. Among the doctors, 61.5% have attained a Master’s degree, 24 are doctoral advisors for Ph.D. students, and 115 are advisors for graduate students. In 2019, there were 3.63 million outpatient visits and 113,000 inpatient visits.
Shenzhen People’s Hospital has 16 provincial key clinical research disciplines. They are the Pulmonary and Critical Care Medicine Dept., the Nephrology Dept., the Gastroenterology Dept., the Infectious Disease Dept., the Endocrinology Dept., the Chest Surgery Dept., the Oral Science Dept., the Anesthesiology Dept., the Gynecology Dept., the Obstetrics Dept., the Neonatal Dept. the Emergency Dept., the Pathology Dept., the Clinical Lab., the Clinical Nursing Dept. and the Radiology Dept. (including CT, Radiology, Ultrasonography, Intervention and Nuclear Medicine). There are also 2 Guangdong provincial engineering technology research centers, 14 Shenzhen municipal-level key medical departments with 7 excellent disciplines, 3 research institutes, 3 municipal level key laboratories, 5 Shenzhen municipal-level engineering technology research centers, and 1 national clinical trial center in the hospital.
In 2003, the hospital introduced the first surgical robot ZEUS. In April 2004, ZEUS accomplished its first laparoscopic cholecystectomy, which was the first surgery of this kind done by a robot in mainland China. In 2013, the Minimally Invasive Diagnosis & Treatment Center was appraised to be one of the top Cryotherapy Training centers in Asia. In 2014, the world’s first single-hole thoracoscopic segmental resection was successfully done in the Chest Surgery Department. The procedure was then published in an international medical journal, representing that the hospital’s early lung cancer treatments were in line with the international standard. Furthermore, Shenzhen People’s Hospital was certified as one of the National Chest Pain Centers in September 2015. In October that year, it officially opened the Assisted Reproductive Care Center. The high-quality medical care of the hospital has attracted the attention from the media and a large number of patients not only from Shenzhen and its surrounding areas, but also from Hong Kong and Macao. Meanwhile, it was selected to be one of the first top-nine hospitals of Guangdong province in June 2018. In January 2017, it was identified as the Prenatal Diagnosis Special Technical Guidance Center of Guangdong Province, the Maternity Intensive Care Center of Guangdong Province, and the Neonatal Intensive Care Center of Guangdong Province. In December that year, it was recognized as the “Smart Hospital” in Guangdong. Besides, it passed the re-examination for Grade 3A level hospitals in China. In the same year, it received the award of Model Hospital of Medical Service Improvement Action Plan. Furthermore, it was selected to be one of the first nine hospitals in the “Dengfeng Plan” by the Government of Guangdong and the Provincial Commission of Health and Family Planning in June 2018.
The hospital is one of the national resident training centers. The Pulmonary and Critical Care Medicine Department, which is the post-doctoral innovated training center of Jinan University, was selected as the first national fellowship training center outside of Guangzhou in Guangdong Province. In 2015, the Translational Medicine Collaborative Innovation Center was founded, integrating all key laboratories, medical engineering centers (platforms) and post-doctoral education bases to solve the problem of inconsistent application and implementation, and to build a unified laboratory for immune biochemistry, molecular biology, genetic testing and animal modeling. At the same time, the hospital invested in special functional equipment to meet the needs of various specialties. It was used as the main research base of the hospital to carry out major clinical research and clinical technology research projects. In 2017, the hospital won the second prize of the National Science and Technology Progress Award, and the first and second prize of “the First Resident Standardized Clinical Skill Training Competition” in Shenzhen. Now, the hospital has 16 teaching and research sections, including internal medicine, surgery, obstetrics and gynecology, pediatrics, and so on. With 98 doctoral advisors, the hospital enrolls over 730 postgraduate students, 40 Ph.D. students and 260 undergraduates, and trains over 130 interns and 120 fellows each year.
Over the years, the hospital has been selecting promising young doctors to get further education and training in world-famous universities and hospitals. Among them are Yale University, New York-Presbyterian Hospital, University of Miami Medical school, University of Pennsylvania Medical School, Harvard Medical School (Massachusetts General Hospital, Beth Israel Deaconess Medical Center), Huston Methodist Hospital, Sunderland University, VUB-Vrije Universiteit Brussel, Curtin University, Simon Fraser University, National University of Singapore, Prince of Wales Hospital, and Queen Mary Hospital of University of Hong Kong. It is during the continued education that they obtained new techniques and gained a better understanding of not only their own majors but also the trends of their fields and the general medical science.
Our hospital has been actively collaborating with top international universities and hospitals, including Medical School of Nuremburg University, Bremerhaven Central Hospital, University College London, University of Edinburgh, Western Ontario University Transplant Center, Huston Methodist Hospital, Lilly University Medical Center, Chonnan National University Hospital and Da Tianxuan Hospital. Our hospital has 25 collaborative teams granted by “the Three Famous Projects” program of Shenzhen government. These teams are led by internationally or nationally renowned professors, namely Academician Zhong Nanshan’s Respiratory Disease team from Guangzhou Institute of Respiratory Disease, Academician Chen Xiangmei’s Nephrology team from Chinese PLA General Hospital, Professor Zhang Xu’s Urology Surgery team from Chinese PLA General Hospital, Professor Xu Ke’s Intervention Medicine team from the 1st hospital of China Medical Universigy, Professor Huo Yong’s Cardiovascular team from Peking University First Hospital, Professor Liu Jin’s Anesthesiology team from West China Hospital, Sichuan University, Professor Ding Yanming’s Nursing team from Peking University First Hospital , Academician Ruan Changgeng’s Hepatopathy team from Jiangsu Institute of Hematology, Academician Gu Yudong’s Hand Surgery team from Huashan Hospital, Academician Han Deming’s Otolaryngology team from Otolaryngology Hospital of Beijing Medical Center, Academician Zhang Yun’s Ultrasound team from QiLu Hospital of Shandong University, Academician Robert C. Malenka’s Brain Cognitive Science team from the National Academy of Science, Professor Zeng Xiaofeng’s Rheumatosis team from Peking Union Medical College Hospital, Professor Gary Royle’s Oncology team from University College London, Professor Seema Khan’s Surgery team from Northwestern University, and a Breast Surgery team led by specialists from Johns Hopkins University. With all these collaborative programs, our hospital has attracted more talents, brought in unprecedented opportunities for development, and improved overall competitiveness.
Wechat
